chr11-33700583-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001166692.2(C11orf91):āc.158G>Cā(p.Gly53Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000181 in 1,458,764 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001166692.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C11orf91 | NM_001166692.2 | c.158G>C | p.Gly53Ala | missense_variant | 1/2 | ENST00000379011.5 | NP_001160164.1 | |
C11orf91 | XM_017017053.2 | c.158G>C | p.Gly53Ala | missense_variant | 2/3 | XP_016872542.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C11orf91 | ENST00000379011.5 | c.158G>C | p.Gly53Ala | missense_variant | 1/2 | 1 | NM_001166692.2 | ENSP00000368296 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00101 AC: 154AN: 151984Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.0000376 AC: 3AN: 79872Hom.: 0 AF XY: 0.0000657 AC XY: 3AN XY: 45666
GnomAD4 exome AF: 0.0000842 AC: 110AN: 1306666Hom.: 0 Cov.: 34 AF XY: 0.0000668 AC XY: 43AN XY: 643340
GnomAD4 genome AF: 0.00101 AC: 154AN: 152098Hom.: 2 Cov.: 33 AF XY: 0.000955 AC XY: 71AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.158G>C (p.G53A) alteration is located in exon 1 (coding exon 1) of the C11orf91 gene. This alteration results from a G to C substitution at nucleotide position 158, causing the glycine (G) at amino acid position 53 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at